Caleres, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CAL research report →
Range $18 – $35
Price Chart
About the company
Caleres, Inc. is a long-standing company primarily involved in the design, sourcing, retail, and wholesale distribution of various footwear products. Its operations span the United States, Canada, China, and Guam, organized into two main divisions: Famous Footwear and Brand Portfolio.
- CEO
- John W. Schmidt
- IPO
- 1980
- Employees
- 10,000
- HQ
- Saint Louis, MO, US
Get TickerSpark's AI analysis on CAL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $411.47M
- P/E
- 7.61
- Fwd P/E
- 7.62
- PEG
- -0.00
- P/S
- 0.14
- P/B
- 0.59
- EV/EBITDA
- 10.33
- Div Yield
- 2.29%
- Gross Margin
- 46.25%
- Op Margin
- 3.45%
- Net Margin
- 1.84%
- ROE
- 8.38%
- ROIC
- 4.31%
Latest fiscal year · YoY change
- Revenue
- $2.76B+1.3%
- Gross Profit
- $1.18B-3.0%
- Op Income
- $28.98M
- Net Income
- $-7,054,000-106.6%
- EPS
- $-0.22-107.1%
- OCF Growth
- -4.1%
- FCF Growth
- -41.6%
- 52W High
- $15.04
- 52W Low
- $8.80
- 50D MA
- $12.84
- 200D MA
- $12.54
- Beta
- 0.76
- RSI (14)
- 47
- Avg Volume
- 514.92K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Caleres delivered a better-than-expected quarter driven by strong Brand Portfolio growth and margin expansion, while Famous Footwear remained pressured by softer lifestyle athletic demand and back-to-school timing shifts.· September 9, 2026
- Second-quarter adjusted results came in above expectations, with margins and earnings ahead of plan.
- Sales were $695 million, up 5.6%; adjusted EPS was $0.47 versus $0.35 last year.
- Consolidated gross margin, excluding the tariff refund recovery, was 46.8%, up 340 bps year over year.
- Brand Portfolio grew across wholesale, DTC, and international, while Famous Footwear sales fell 6.3% and comps fell 5.9%.
- Management raised the low end of full-year adjusted EPS guidance but kept the high end unchanged.
Second-quarter sales were $695 million, up 5.6% year over year. Excluding Stuart Weitzman, sales decreased 0.8%; Brand Portfolio organic sales increased 8.2% and were up 23.6% including Stuart Weitzman. Famous Footwear sales were down 6.3% with comparable sales down 5.9%, and adjusted EPS was $0.47 versus $0.35 last year. Consolidated gross margin, excluding the $57.4 million IEEPA tariff refund recovery, was 46.8%, up 340 bps; Brand Portfolio gross margin was 49.1%, up 880 bps; Famous gross margin was 42.7%, down 100 bps. Operating earnings were $22.1 million and operating margin was 3.2%. For Q3, management expects consolidated sales to increase in the low single digits, gross margin to improve 150 to 200 bps, and GAAP EPS of $0.62 to $0.70. For full-year 2026, guidance is consolidated sales up low- to mid-single digits, adjusted EPS of $1.50 to $1.65, consolidated gross margin up 180 to 220 bps, and capital expenditures of about $50 million to $55 million.
Jay Schmidt said 2026 is a build-back year focused on restoring earnings power, strengthening the business foundation, integrating Stuart Weitzman, and positioning Caleres for more durable growth. He emphasized that the brand portfolio is gaining share and seeing broad-based momentum, especially in fashion footwear and international markets, while Famous Footwear is being actively repositioned away from softer lifestyle athletic. His tone was confident but pragmatic: the company is making progress, but management is still working through assortment and inventory resets at Famous.
Dan Karpel highlighted that Q2 included $57.4 million of IEEPA tariff refunds in GAAP results, with $55.6 million reducing cost of sales and $1.8 million in other income. He said consolidated gross margin excluding that recovery was 46.8%, up 340 bps, driven by the Brand Portfolio, while Famous gross margin fell to 42.7% due to industry-wide promotional pressure in lifestyle athletic. He also noted Q2 cash of $50.9 million, borrowings of $288 million, availability under the revolver of $357.3 million, and inventory of $754.2 million, with Brand Portfolio inventory down 5.6% excluding Stuart Weitzman. Guidance implies $16 million to $17 million of interest expense, a 24% to 26% full-year tax rate, and SG&A roughly flat to slightly deleveraging for the year.
Analysts focused on two main issues: how much of Brand Portfolio growth came from North America versus international, and how durable the improvement could be in Famous Footwear’s athletic mix. Management said the order book is consistent with Q3 guidance and that they are not seeing unusual volatility, while also noting international remains less than 10% of total sales and has significant runway. On Famous, they said the athletic-to-fashion mix is being rightsized, premium product is outperforming in Flare stores, and markdown pressure should remain elevated as they clean up inventory. Questions on Stuart Weitzman centered on the path to breakeven; management said integration is progressing well, China is ahead of plan, and the brand is in better shape than earlier in the year.
The call showed strong momentum in the Brand Portfolio, with broad-based growth, 49.1% gross margin, and continued share gains in women’s fashion footwear. Management sounded increasingly confident in Stuart Weitzman’s path to breakeven and in international as a long runway growth opportunity, while also citing encouraging trends in boots, dress footwear, and premium product. The company also raised the low end of full-year adjusted EPS guidance.
Famous Footwear remains the main pressure point, with sales and comps down in Q2, ongoing weakness in lifestyle athletic, and continued promotional activity expected as inventories are reset. Management acknowledged that Q3 and the back half will still face markdown pressure and that certain categories are being rightsized rather than showing a clean recovery. Tariff uncertainty also remains in the guide, with management assuming new tariffs will largely replace prior IEEPA tariffs.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.7%
- Shares Outstanding
- 33.59M
- Float Shares
- 31.82M
of shares held by institutions
173 13F filers
Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Fmr LLC | 5.04M | ▼ 45.87K |
| Blackrock, Inc. | 3.95M | ▲ 1.02M |
| Vanguard Group Inc | 2.00M | ▼ 428.58K |
| Vanguard Capital Management LLC | 1.44M | ▼ 36.50K |
| American Century Companies Inc | 1.32M | ▲ 111.49K |
| Neuberger Berman Group LLC | 1.27M | ▲ 128.27K |
| Dimensional Fund Advisors LP | 1.26M | ▼ 185.12K |
| State Street Corp | 1.02M | ▼ 27.35K |
| Arrowstreet Capital, Limited Partnership | 917.01K | ▼ 557.66K |
| Invenomic Capital Management LP | 902.63K | ▼ 201.38K |
| Sixth Street Partners Management Company, L.P. | 900.82K | ▲ 900.82K |
| Charles Schwab Investment Management Inc | 900.82K | ▼ 122.16K |
Held by 174 ETFs
Biggest fund positions in CAL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 11, 26 | Hill Willis | other | 27,132 |
| Sep 11, 26 | Freidman Daniel R | other | 29,303 |
| Sep 11, 26 | Costello Brian P | other | 29,845 |
| Sep 11, 26 | Karpel Daniel L | other | 29,845 |
| Sep 11, 26 | Schmidt John W | other | 116,280 |
| Sep 11, 26 | Welter Kathleen K | other | 21,706 |
| Sep 11, 26 | Burke Thomas C | other | 26,318 |
| Sep 8, 26 | Welter Kathleen K | other | 1,882 |
| Aug 1, 26 | LANGENSTEIN MOLLY | other | 1,950 |
| Aug 1, 26 | KLEIN WARD M | other | 1,950 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CAL coverage
Recent articles, reports, and earnings notes.
No research on CAL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CAL report →Caleres, Inc. $CAL Stock Holdings Decreased by Squarepoint Ops LLC
defenseworld.net · Sep 25
Immersion (NASDAQ:IMMR) versus Caleres (NYSE:CAL) Head to Head Survey
defenseworld.net · Sep 22
Caleres, Inc. (CAL) Q2 2027 Earnings Call Transcript
seekingalpha.com · Sep 9
Caleres Continues To Prove Why The Shoe Is On The Right Foot
seekingalpha.com · Sep 9
Caleres Q2 Earnings Call Highlights
marketbeat.com · Sep 9
Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday
benzinga.com · Sep 9
Caleres Inc. (CAL) Tops Q2 Earnings Estimates
zacks.com · Sep 9
Caleres Reports Second Quarter 2026 Results
businesswire.com · Sep 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.